Prof. Alişan Yıldıran

Publication Network

Articles 103

1. When Immunodeficiency Isn't the Whole Story: CTLA-4 Haploinsufficiency and Munchausen by Proxy Syndrome

Karadag S. I. K., Usta M. B., Karabekiroğlu K. M. Z., Yıldıran A.

KLINISCHE PADIATRIE , 2025 (SCI-Expanded, Scopus)

2. Tracing a Rare Genetic Disease: Familial Congenital CD59 Deficiency and Carrier Cases Identified Through Village Screening

Ilknur K. K. S., Medine K. A., Huseyin K., Uğurtay E., Cansu C., Yıldıran A.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.47, no.3, pp.109-114, 2025 (SCI-Expanded)

3. PFAPA Syndrome: Evaluation of Clinical Findings, Immunological Alterations, and Treatment Approaches

Karadag S. I. K., Cepni E. B., Gunduz Z. G., Yıldıran A.

GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS , no.2, pp.125-132, 2024 (ESCI)

4. Primary immune regulatory disorders (PIRD): expanding the mutation spectrum in Turkey and identification of sixteen novel variants

AYKUT A., DURMAZ A., Karaca N., Gulez N., Genel F., Celmeli F., et al.

IMMUNOLOGIC RESEARCH , vol.72, no.4, pp.714-726, 2024 (SCI-Expanded) Sustainable Development

5. The role of basophil activation test in venom ımmunotherapy: comparative evaluation with specific IgE and skin prick tests, ınnovative approaches.

Kokcu Karadag S. I., Özen Çökelez S., Bekar Çepniler E., Abdullayev E., Terzi O., Özçeker D., et al.

European annals of allergy and clinical immunology , 2024 (ESCI)

6. Nasopharyngeal ACE2, CD147, and TMPRSS2 expressions in MIS-C patients

Karadag Alpaslan M., KÖKCÜ KARADAĞ Ş. İ., CAN C., Erdeniz E. H., Turgut Uğurtay E., YILDIRAN A.

Annals of Medical Research , vol.31, no.7, pp.510-515, 2024 (Peer-Reviewed Journal)

7. Immunology and Genetics of Autism Spectrum Disorders and Retrospective Evaluation of Clinical Responses to Regular Immunoglobulin Replacement Therapy

Yıldıran A.

Journal of Pediatric Perspectives , vol.12, no.2, pp.18586-18600, 2024 (Peer-Reviewed Journal)

8. One Virus, Two Diseases: Evaluation of Clinical and Immunological Differences in Covid-19 and Multisystem Inflammatory Syndrome Cases

Karadag S. I. K., Erdeniz E. H., Özkan E., Yıldıran A.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , no.1, pp.82-90, 2024 (ESCI, TRDizin)

9. Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome

BİLGİÇ ELTAN S., Nain E., Catak M. C., Ezen E., Sefer A. P., Karimi N., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.44, no.1, 2024 (SCI-Expanded) Sustainable Development

10. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency

Taghizade N., Babayeva R., Kara A., Karakus I. S., Catak M. C., Bulutoglu A., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , no.6, pp.1634-1645, 2023 (SCI-Expanded) Sustainable Development

11. Immunophenotype, Clinical Effect, and Comparison of TNFRSF13B/TACI Mutations: A Single-Center Retrospective Cohort Study of 34 Patients

Cepniler E., Abdullayev E., Karadag S. I. K., Yıldıran A.

TURKISH JOURNAL OF IMMUNOLOGY , no.3, pp.117-126, 2023 (ESCI)

12. Intrafamilial clinical variability of CTLA-4 insufficiency hindering early diagnosis

KÖKCÜ KARADAĞ Ş. İ., HANCIOĞLU G., Akcam B., Altundağ E., BARIŞ S., Yıldıran A.

KLINISCHE PADIATRIE , 2023 (SCI-Expanded)

13. Pigment epithelium-derived factor enhances peripheral nerve regeneration through modulating oxidative stress and stem cells An experimental study

Önger M. E., Altun G., Yıldıran A.

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY , vol.306, no.10, pp.2621-2635, 2023 (SCI-Expanded)

14. Clinical Importance of Immunophenotyping of Peripheral Blood Lymphocyte Subsets in Adult COVID-19 Patients: A Cross-Sectional Study

Kuruoglu T., Temoçin F., atilla a., YILDIRAN A., TANYEL E.

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , vol.28, no.3, pp.394-404, 2023 (ESCI)

15. MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia

YILDIRAN A.

JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , 2023 (Scopus)

16. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency

Levy R., Gothe F., Momenilandi M., Magg T., Materna M., Peters P., et al.

JOURNAL OF EXPERIMENTAL MEDICINE , vol.220, no.2, 2022 (SCI-Expanded)

17. Case Series Evaluating Lymphocyte Subgroups at Diagnosis and After Treatment in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children

Karadag S. I. K., Erdeniz E. H., Akyüz Özkan E., Yıldıran A.

JOURNAL OF PEDIATRIC INFECTION , vol.16, no.4, pp.262-267, 2022 (ESCI)

18. The effects of thymoquinone and cytozine arabinoside on apoptosis and cell proliferation in acute myeloide leukemia

ALTUN A., Kara N., TURAL Ş., YILDIRAN A., TOMAK L.

Global Journal of Cancer Theraphy , vol.8, no.1, pp.40-45, 2022 (Peer-Reviewed Journal)

19. The effects of thymoquinone and cytozine arabinoside on apoptosis and cell proliferation in acute myeloide leukemia

ALTUN A., KARA N., TURAL Ş., YILDIRAN A., TOMAK L.

Global Journal of Cancer Therapy , vol.8, no.1, pp.40-45, 2022 (Peer-Reviewed Journal)

20. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency

Catak M. C., Akcam B., Eltan S. B., Babayeva R., Karakus I. S., Akgun G., et al.

ALLERGY , vol.77, no.10, pp.3108-3123, 2022 (SCI-Expanded) Sustainable Development

21. Chronic Granulomatous Disease with Recurrent Tuberculosis at Adolescent Child

Karadag S. I. K., Kutlug S., Uzun O., KÖKER M. Y., Yıldıran A.

JOURNAL OF PEDIATRIC INFECTION , vol.16, no.2, 2022 (ESCI)

22. Tekrarlayan Tüberküloz ile Kronik Granülomatöz Tanısı Konulan Adölesan

YILDIRAN A., KUTLUĞ Ş., KÖKER M. Y., UZUN O.

COCUK ENFEKSIYON DERGISI , vol.16, 2022 (ESCI)

23. Potential Effects of Stem Cells Derived from the Peripheral Nerve and Adipose Tissue after the Nerve Crush Injury in Control and Obese Rats

Kustepe E. K., ALTUNKAYNAK B. Z., Alkan I., Kivrak E. G., Yıldıran A., Geuna S.

JOURNAL OF INVESTIGATIVE SURGERY , vol.35, no.5, pp.1021-1033, 2022 (SCI-Expanded)

24. Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes

Bayram O., HASKOLOĞLU Z. Ş., Bayrakoglu D., Bal S. K., Islamoglu C., Cipe F. E., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.7, pp.1563-1573, 2021 (SCI-Expanded)

25. Impaired respiratory burst contributes to infections in PKC-deficient patients

Neehus A., Moriya K., Nieto-Patlan A., Le Voyer T., Levy R., Ozen A., et al.

JOURNAL OF EXPERIMENTAL MEDICINE , vol.218, no.9, 2021 (SCI-Expanded)

26. Reversal clinical and immunological effects of abatacept in patients with LRBA and CTLA4 deficiencies

BARIŞ S., Babayeva R., Catak M. C., Baser D., BİLGİÇ ELTAN S., Akgun G., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.77, 2021 (SCI-Expanded)

27. Impaired respiratory burst contributes to infections in PKC delta-deficient patients

Neehus A. L., Moriya K., Patlan A. N., Le Voyer T., Levy R., Yıldıran A., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , vol.51, pp.348, 2021 (SCI-Expanded)

28. The Efficacy of Long-Term Voriconazole Prophylaxis on Seven Patients with Chronic Granulomatous Disease and Review of the Literature

KUTLUĞ Ş., KÖKÇÜ Ş. İ. K., ŞENSOY S. G., BİRİNCİ A., KÖKER M. Y., YILDIRAN A.

Çocuk Enfeksiyon Dergisi , vol.15, no.4, pp.203-209, 2021 (ESCI)

29. Multiplex PCR-Based Newborn Screening for Severe T and B-Cell Lymphopenia: The first Pilot Study in Turkey

Kutlug S., Karadağ Alpaslan M., Hancioglu G., Ozkan S. E. O., Yesilirmak D. C., Bulut H., et al.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , vol.55, no.4, pp.551-559, 2021 (ESCI, TRDizin)

30. An examination of the relationship between regulatory T cells and symptom flare-ups in children and adolescents diagnosed with chronic tic disorder and Tourette syndrome

Yildirim Z., Karabekiroglu K., Yıldıran A., Celiksoy M. H., Artukoglu B., Baykal S., et al.

NORDIC JOURNAL OF PSYCHIATRY , vol.75, no.1, pp.18-24, 2021 (SCI-Expanded, SSCI, Scopus)

31. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency

KIYKIM A., Ogulur I., Dursun E., Charbonnier L. M., Nain E., ÇEKİÇ Ş., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , vol.7, no.8, pp.2790-2815, 2019 (SCI-Expanded)

32. LINE-1-Mediated AluYa5 Insertion Underlying Complete Autosomal Recessive IFN-gamma R1 Deficiency

Rosain J., Deswarte C., Hancioglu G., Oleaga-Quintas C., Kutlug S., Kartal İ., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.39, no.7, pp.739-742, 2019 (SCI-Expanded)

33. Development of multiple gallstones in a child with lipopolysaccharide-responsive beige-like anchor protein mutation

Kutlug S., Boztug K., Yıldıran A.

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , vol.44, no.3, pp.332-335, 2019 (SCI-Expanded)

34. A Case of Ataxia-telangiectasia Presented With Hemophagocytic Syndrome

Celiksoy M. H., Cubuk P. O., Guner S. N., Yıldıran A.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.40, no.8, 2018 (SCI-Expanded)

35. Seven chronic granulomatous disease cases in a single-center experience and a review of the literature

Kutlug S., Sensoy G., Birinci A., SARAYMEN B., KÖKER M. Y., Yıldıran A.

ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY , vol.36, no.1, pp.35-41, 2018 (SCI-Expanded)

36. The rote of active B cells in allergen immunotherapy

Celiksoy M. H., Sancak R., Yıldıran A.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , vol.45, no.5, pp.439-444, 2017 (SCI-Expanded)

37. An evaluation of vitamin D levels in children with seasonal allergic rhinitis during pollen season

Kutlug S., Kilic M., Bilgici B., Paksu S., Yıldıran A., SANCAK R.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.28, no.5, pp.446-451, 2017 (SCI-Expanded)

38. Heterozigot S52N Mevolinat Kinaz Mutasyonu ile İlişkili Şiddetli Hiper IgD Sendromu

Çeliksoy M. H., BERDELİ A., COMBA A., ÇALTEPE G., YILDIRAN A.

ASTIM ALLERJI IMMUNOLOJI , vol.15, no.2, pp.111-116, 2017 (Peer-Reviewed Journal)

39. A Case of Acute Generalised Exanthematous Pustulosis Induced by Paracetamol

Kutlug S., Celiksoy M. H., Eroglu B., Yıldız L., Yıldıran A.

ASIM ALLERJI IMMUNOLOJI , vol.15, no.1, pp.49-54, 2017 (ESCI)

40. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Patients in the Black Sea Region of Turkey

YILDIRAN A., ÇELİKSOY M. H., BORTE S., GÜNER Ş. N., ELLİ M., FIŞGIN T., et al.

Turkish Journal of Hematology , vol.34, no.4, pp.345-349, 2017 (SCI-Expanded)

41. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Patients in the Black Sea Region of Turkey

Yıldıran A., Celiksoy M. H., Borte S., Guner S. N., Elli M., Fisgin T., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.34, no.4, pp.345-349, 2017 (SCI-Expanded)

42. Chronic granulomatous disease Three different clinical presentation

Celiksoy M. H., KÖKER M. Y., ŞENSOY S. G., belet n., CEYHAN BİLGİCİ M. N., YILDIRAN A.

İnönü Üniversitesi Tıp Fakültesi Dergisi , vol.24, pp.1, 2017 (Peer-Reviewed Journal)

43. Severe Hyper IgD Syndrome Associated with Heterozygote S52N Mevalonate Kinase Mutation

Celiksoy M. H., BERDELİ A., Comba A., Çaltepe G., Yıldıran A.

ASTIM ALLERJI IMMUNOLOJI , vol.15, no.2, pp.111-114, 2017 (ESCI, TRDizin) Sustainable Development

44. Vesicourethral Reflux-Induced Renal Failure in a Patient with ICF Syndrome Due to a Novel DNMT3B Mutation

Kutlug S., Ogur G., Yılmaz A., Thijssen P. E., Abur Ü., Yıldıran A.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A , vol.170, no.12, pp.3253-3257, 2016 (SCI-Expanded)

45. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene iscovery

Scott E. M., Halees A., Itan Y., Spencer E. G., He Y., Azab M. A., et al.

NATURE GENETICS , vol.48, no.9, pp.1071-1079, 2016 (SCI-Expanded) Sustainable Development

46. Is parturition-timing machinery related to the number of inhibitor CD94/NKG2A positive uterine natural killer cells?

Mazi E., Altunkaynak Z., Aydin I., Kocak I., Guven D., Türkmen A. P., et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.294, no.2, pp.261-265, 2016 (SCI-Expanded)

47. A comparison of B cell subsets in primary immune deficiencies that progress with antibody deficiency and age-matched healthy children

Celiksoy M. H., Yildiran A.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , vol.44, no.4, pp.331-340, 2016 (SCI-Expanded)

48. Could familial Mediterranean fever gene mutations be related to PFAPA syndrome?

Celiksoy M. H., Ogur G., Yaman E., Abur Ü., Fazla S., SANCAK R., et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY , vol.27, no.1, pp.78-82, 2016 (SCI-Expanded)

49. Pulmonary hypoplasia presenting with recurrent wheezing in an infant

Celiksoy M. H., TANDER B., Asilioglu N., Barış Y. S., Yıldıran A.

CLINICAL RESPIRATORY JOURNAL , no.4, pp.497-500, 2015 (SCI-Expanded, Scopus) Sustainable Development

50. Comparison of major lymphocyte subpopulations and recent thymic emigrants in patients with ataxia telangiectasia and age-matched healthy groups

Celiksoy M. H., Topal E., Yildiran A.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA , vol.43, no.5, pp.477-481, 2015 (SCI-Expanded)

51. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood

Boisson-Dupuis S., Bustamante J., El-Baghdadi J., Camcioglu Y., Parvaneh N., El Azbaoui S., et al.

IMMUNOLOGICAL REVIEWS , vol.264, no.1, pp.103-120, 2015 (SCI-Expanded)

52. c.761C > T Mutation Linked Hyper IgM Syndrome Presenting with Hypertransaminasemia and Arthritis

Celiksoy M. H., Borte S., İKİNCİOĞULLARI K. A., Ceyhan Bilgici M. N., Karagöz F., KALAYCI A. G., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.31, no.4, pp.420-421, 2014 (SCI-Expanded)

53. Effects of circulating endothelial progenitor cells, serum vascular endothelial growth factor and hypogammaglobulinemia in Perthes disease

SEZGİN H., Gulman B., Cirakli A., Bedir A., Usta D., Coskun S., et al.

ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA , no.6, pp.628-634, 2014 (SCI-Expanded)

54. TLR3 deficiency in herpes simplex encephalitis High allelic heterogeneity and recurrence risk

Lim H. K., Seppanen M., Hautala T., Ciancanelli M. J., Itan Y., Lafaille F. G., et al.

NEUROLOGY , vol.83, no.21, pp.1888-1897, 2014 (SCI-Expanded)

55. Demographic and systemic manifestations of patients diagnosed with ataxia-telangiectasia

ÇATAL F., TOPAL E., ÇELİKSOY M. H., ERMİŞTEKİN H., KUTLUTÜRK K., YILDIRIM N., et al.

Astım Allerji İmmünoloji , vol.12, no.2, pp.83-90, 2014 (Peer-Reviewed Journal)

56. BCG vaccination in patients with severe combined immunodeficiency: Complications, risks, and vaccination policies

Marciano B. E., Huang C., Joshi G., Rezaei N., Carvalho B. C., Allwood Z., et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , vol.133, no.4, pp.1134-1141, 2014 (SCI-Expanded)

57. Demographic and systemic manifestations of patients diagnosed with ataxia-telangiectasia

Catal F., TOPAL E., Celiksoy M. H., Ermistekin H., Kutluturk K., Yildirim N., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.12, no.2, pp.83-90, 2014 (ESCI)

58. Neuroimmune diseases are increasing. Is there a possible vaccine link?

Yıldıran A., Kaplan S., Önger M. E.

JOURNAL OF PEDIATRIC NEUROLOGY , vol.11, no.4, pp.201-209, 2013 (ESCI)

59. Hemophagocytic Bone Marrow Aplasia With Plasma Cells in a RAG2-deficient SCID Case After a Nonconditioned Transplantation From a Fully Matched Sibling

Yıldıran A., Fisgin T., Guner S. N., Kilic M., SANCAK R., Ozyurek E., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.35, no.8, 2013 (SCI-Expanded)

60. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients

KÖKER M. Y., Camcioǧlu Y., Van Leeuwen K., KILIÇ GÜLTEKİN S. Ş., Barlan I., YILMAZ M., et al.

Journal of Allergy and Clinical Immunology , vol.132, no.5, 2013 (SCI-Expanded)

61. The demographic datas of chronic granulomatous disease patients and the comparation of the clinical datas before and after interferon-gamma treatment in our country

Filiz S., KOCACIK UYGUN D. F., Sanal O., Camcioglu Y., SOMER A., Barlan I., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.11, no.3, pp.153-161, 2013 (ESCI)

62. Sarcoid uveitis simulating birdshot chorioretinopathy in a child

Süllü Y., Yıldıran A., Süllü Y., Helek D., Ozkaya O.

Retinal Cases and Brief Reports , vol.6, no.1, pp.7-10, 2012 (Scopus)

63. HLA-haploidentical transplantations for primary immunodeficiencies: A single-center experience

Cipe F. E., DOĞU E. F., Aytekin C., Yuksek M., KENDİRLİ T., YILDIRAN AVCU Y., et al.

PEDIATRIC TRANSPLANTATION , vol.16, no.5, pp.451-457, 2012 (SCI-Expanded) Sustainable Development

64. Immune manifestations in a patient with kabuki syndrome: Case report

Kiliç M., Güner Ş. N., Yılmaz A., Oǧur M. G., Duru F., Yıldıran A.

Turkiye Klinikleri Pediatri , vol.21, no.2, pp.130-132, 2012 (Scopus)

65. Does mode of delivery affect asthma developing in children who had neonatal sepsis?

Aynaci E., SANCAK R., Ozturk F., Bek Y., Aygun H. C., Kucukoduk S., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.10, no.1, pp.31-37, 2012 (ESCI)

66. The Effect of Mode of Delivery on T Regulatory (Treg) Cells of Cord Blood

Yıldıran A., Yurdakul E., Guloglu D., DOĞU E. F., ARSAN S., Arikan M., et al.

INDIAN JOURNAL OF PEDIATRICS , vol.78, no.10, pp.1234-1238, 2011 (SCI-Expanded)

67. A severe 'generalized infantile pustular psoriasis' case healed with low dose cyclosporine A Düşük doz siklosporin A ile i̇yileşen aǧir bir 'yaygin i̇nfantil püstüler psöriazis' vakasi

Yıldıran A., Yıldız L., SANCAK R.

Turkiye Klinikleri Pediatri , vol.20, no.1, pp.77-80, 2011 (Scopus)

68. Comparison of Antifungal Susceptibilities in Candidemic Newborns According to Their Body Weights

Yıldıran A., Belet N., Gunaydin M., Kucukoduk S.

TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI , vol.27, no.3, pp.234-237, 2010 (SCI-Expanded)

69. Childhood sarcoidosis: Two different clinical picture Çocukluk çaǧi sarkoidozu: İki farkli klinik tablo

Yıldıran A., Helek D., Aynaci E., Özkaya O., Şensoy G., Yıldız L., et al.

Journal of Experimental and Clinical Medicine (Turkey) , vol.27, no.2, pp.81-84, 2010 (Scopus)

70. A child diagnosed as IL12R defect with disseminated BCG infection Yaygin BCG enfeksiyonu olan IL12R defekti olgusu

Yıldıran A., Ak E., Akyol Ş., SANCAK R., Picard C., Doǧ F., et al.

Journal of Experimental and Clinical Medicine (Turkey) , vol.27, no.2, pp.85-87, 2010 (Scopus)

71. Fatal acute respiratory distress syndrome in children with combined immunodeficiencies

KENDİRLİ T., DOĞU E. F., İKİNCİOĞULLARI K. A., Aytekin C., YILDIRAN AVCU Y., YILMAZ M., et al.

ASTIM ALLERJI IMMUNOLOJI , vol.7, no.3, pp.180-188, 2009 (ESCI) Sustainable Development

72. Glucocorticoids: As a clinician we use much, we know less

Yıldıran A., Düzgün A., SANCAK R.

Journal of Experimental and Clinical Medicine (Turkey) , vol.26, no.3, pp.102-106, 2009 (Scopus)

73. Serum transforming growth factor-β (TGF-β), matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and tissue inhibitors of metalloproteinase (TIMP-1) levels in childhood asthma

DOĞU E. F., Yıldıran A., Güloǧlu D., Erol Çipe F., Yüksek M., Babacan E., et al.

Turkish Journal of Medical Sciences , vol.38, no.5, pp.415-419, 2008 (SCI-Expanded)

74. An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication

Aytekin C., Yuksek M., DOĞU E. F., Yagmurlu A., YILDIRAN AVCU Y., FİTOZ Ö. S., et al.

PEDIATRIC TRANSPLANTATION , no.4, pp.479-482, 2008 (SCI-Expanded) Sustainable Development

75. An unusual clinical presentation: invasive Candida non-albicans infections in ataxia telangiectasia.

Cipe F., Dogu F., Yildiran A., Yüksek M., Pekacar T., Güriz H., et al.

Journal of investigational allergology & clinical immunology , vol.18, no.6, pp.488-90, 2008 (SCI-Expanded)

76. Reply [2]

Yıldıran A., Ikincioǧullari A.

Turkish Journal of Hematology , vol.23, no.1, pp.72-73, 2006 (Scopus)

77. Recent advances, eosinophils, eosinophilia and hypereosinophilic syndrome.

Bolaman Z., Yıldıran A., İkincioğulları A.

Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.23, no.1, pp.71-3, 2006 (Scopus)

78. Toll-like receptors; integrate innate and adaptive immunity, promise innovative therapies

Yıldıran A., İkincioğullari A.

Journal of Pediatric Infectious Diseases , vol.1, no.4, pp.195-203, 2006 (Scopus)

79. In the light of recent advances: eosinophil, eosinophilia and idiopathic hypereosinophilic syndrome.

Yıldıran A., İkincioğulları A.

Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.22, no.3, pp.107-16, 2005 (Scopus)

80. Pediatric hypereosinophilic syndrome (HES) clinically differs from adult HES, but there is a lack of confirmatory laboratory data

YILDIRAN AVCU Y., Ikinciogullari A.

JOURNAL OF PEDIATRICS , vol.147, no.6, pp.869-870, 2005 (SCI-Expanded) Sustainable Development

81. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder

BİLİCİ M., Yildirim F., Kandil S., Bekaroglu M., YILDIRMIŞ S., DEĞER O., et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , vol.28, no.1, pp.181-190, 2004 (SCI-Expanded) Sustainable Development

82. Transient tachypnea of the newborn (TTN): a role for polymorphisms of surfactant protein B (SP-B) encoding gene?

Tutdibi E., Hospes B., Landmann E., Gortner L., SATAR M., Yurdakök M., et al.

Klinische Padiatrie , vol.215, no.5, pp.248-52, 2003 (SCI-Expanded) Sustainable Development

83. Disseminated Trichosporon asahii infection in a preterm

Yildiran A., Kucukoduk S., Sanic A., Belet N., Guvenli A.

AMERICAN JOURNAL OF PERINATOLOGY , vol.20, no.5, pp.269-271, 2003 (SCI-Expanded)

84. Randomized, double-blinded, placebo-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to non-neutropenic preterm newborns between 33 and 36 weeks with presumed sepsis

Küçüködük S., Sezer T., Yıldıran A., Albayrak D.

Scandinavian Journal of Infectious Diseases , vol.34, no.12, pp.893-897, 2002 (SCI-Expanded)

85. Haemoperfusion may be useful in phenprobamate and polypharmacy intoxication of paediatric patients [3]

Ali Tasdemir H., Yıldıran A., Islek I., SANCAK R., Dilber C.

Nephrology Dialysis Transplantation , vol.17, no.5, pp.941, 2002 (SCI-Expanded)

86. Haemoperfusion may be useful in phenprobamate and polypharmacy intoxication of paediatric patients

TAŞDEMİR H. A., YILDIRAN A., İŞLEK İ., SANCAK R., DİLBER C.

Nephrol Dial Transplant , vol.17, no.5, pp.941, 2002 (Peer-Reviewed Journal)

87. Proliferation of myeloid lineage cells and apoptosis of lymphoblastic leukemic cells induced by short-course high-dose methylprednisolone in patients with acute lymphoblastic leukemia

Yıldıran A., Erduran E., TEKELİOĞLU Y., Dilber E., Gedik Y.

Turkish Journal of Pediatrics , vol.44, no.2, pp.116-121, 2002 (SCI-Expanded)

88. Bone mineral density in children with cerebral palsy

Tasdemir H. A., Buyukavci M., Akcay F., Polat P., Yildiran A., Karakelleoglu C.

Pediatrics International , vol.43, no.2, pp.157-160, 2001 (SCI-Expanded)

89. Necrotising enterocolitis: Analysis of 62 cases Nekrotizan enterokolit: 62 Olgunun deǧerlendirilmesi

ASLAN Y., Ayvaz A., Yıldıran A., Orhan F., Saruhan H., Peru H., et al.

Pediatrik Cerrahi Dergisi , vol.15, no.1, pp.20-27, 2001 (Scopus)

90. Type e brachydactyly with short stature in a mother and her two daughters (A case report)

Yıldıran A., Ökten A., Gedik Y.

Ondokuz Mayis Universitesi Tip Dergisi , vol.18, no.3, pp.204-208, 2001 (Scopus)

91. Sepsis and multiple brain abscesses caused by Salmonella paratyphi B in an infant: successful treatment with sulbactam-ampicillin and surgical drainage.

Yildiran A., Siga E., Baykal S., Okten A.

The Turkish journal of pediatrics , vol.43, no.1, pp.85-7, 2001 (SCI-Expanded)

92. Abnormalities may be related defective somitogenesis: Multiple vertebral segmentation defects and neural tube defects

Odaci E., Yıldıran A., KÜÇÜKÖDÜK Ş., Çiftçi N.

Ondokuz Mayis Universitesi Tip Dergisi , vol.18, no.3, pp.216-224, 2001 (Scopus)

93. Microscopic nephrocalcinosis and hypercalciuria in nephrotic syndrome

Mocan H., Yıldıran A., Çamlibel T., Kuzey G.

HUMAN PATHOLOGY , no.11, pp.1363-1367, 2000 (SCI-Expanded)

94. Successful treatment of reactive hemophagocytic syndrome with cyclosporin A and intravenous immunoglobulin.

Erduran E., Gedik Y., Sen Y., Yildiran A.

The Turkish journal of pediatrics , vol.42, no.2, pp.168-70, 2000 (SCI-Expanded)

95. Asplenia in a patient with Fanconi's anemia-like congenital aplastic anemia.

Erduran E., Okten A., Kaya G., Yildiran A.

The Turkish journal of pediatrics , vol.42, no.2, pp.155-7, 2000 (SCI-Expanded)

96. Co-trimoxazole-induced toxic epidermal necrolysis treated with high dose methylprednisolone

Soylu H., Akkol N., ERDURAN E., ASLAN Y., Gunes Z., Yıldıran A.

Annals of Medical Sciences , vol.9, no.1, pp.38-40, 2000 (Scopus)

97. Semantic and nosological confusions on multiple vertebral segmentation defects

Yıldıran A., Odaci E.

Pediatric Neurosurgery , vol.33, no.3, pp.168, 2000 (SCI-Expanded)

98. Apoptotic effects of heparin on lymphoblasts, neutrophils, and mononuclear cells: results of a preliminary in vitro study.

Erduran E., Tekelioğlu Y., Gedik Y., Yildiran A.

American journal of hematology , vol.61, no.2, pp.90-3, 1999 (SCI-Expanded)

99. Breath holding spells in 91 children and response to treatment with iron

Mocan H., YILDIRAN AVCU Y., ORHAN F., ERDURAN E.

ARCHIVES OF DISEASE IN CHILDHOOD , vol.81, no.3, pp.261-262, 1999 (SCI-Expanded) Sustainable Development

100. Multiple fungal brain abscess in a child with acute myeloblastic leukemia

ERDURAN E., YILDIRAN AVCU Y., Gedik Y.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.15, no.5, pp.463-466, 1998 (SCI-Expanded) Sustainable Development

101. Multiple vertebral segmentation defects. Brief report of three patients and nosological considerations.

Aslan Y., Erduran E., Mocan H., Yildiran A., Okten A., Gedik Y.

Genetic counseling (Geneva, Switzerland) , vol.8, no.3, pp.241-8, 1997 (Scopus)

102. The role of high dose methylprednisolone and splenectomy in the accelerated phase of chédiak-higashi syndrome

ASLAN Y., ERDURAN E., Gedik Y., Mocan H., Yıldıran A.

Acta Haematologica , vol.96, no.2, pp.105-107, 1996 (Scopus)

103. A case of VATER association associated with 9qh+.

Aynaci F. M., Celep F., Karagüzel A., Baki A., Yildiran A.

Genetic counseling (Geneva, Switzerland) , vol.7, no.4, pp.321-2, 1996 (Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 41

1. Yetişkin Covid-19 hastalarında periferik kan lenfosit alt kümelerinin immünofenotiplemesinin klinik önemi: Kesitsel bir çalışma

KURUOĞLU T., TEMOÇİN F., ATİLLA A., YILDIRAN A., TANYEL E.

9. BUHASDER KONGRESİ, Antalya, Turkey, 24 - 28 November 2021, (Summary Text)

2. Çocuklarda COVİD19 ile İlişkili Multisistam enflamatuar sendromunda İVİG tedavisinini önemi ve hastaların lenfosit alt gruplarının ilk başvuru sırasında ve birinci ayda değerlendirilmesi- Tek merkez deneyimi

KÖKCÜ KARADAĞ Ş. İ., ERDENİZ E. H., AKYÜZ ÖZKAN E., YILDIRAN A.

43. Pediatri Günleri 22. Pediatri Hemşireliği Günleri, Turkey, 30 May 2021, pp.1-379, (Summary Text)

3. Bir virüs iki hastalık: COVİD-19 ve MİS-C olgularının klinik ve immünolojik farklılıklarının değerlendirilmesi

KÖKCÜ KARADAĞ Ş. İ., ERDENİZ E. H., AKYÜZ ÖZKAN E., YILDIRAN A.

43. Pediatri Günleri 22. Pediatri Hemşireliği Günleri, Turkey, 30 May 2021, pp.1-379, (Summary Text)

4. A rare cause of recurrent juvenile parotitis:NOD2Mutation (c.2798+158C> T)

KÖKCÜ KARADAĞ Ş. İ., AKAR Ö. S., YILDIRAN A.

19th biennial Meeting of the European Society for Immunodeficiencies, England, 14 October 2020, (Full Text)

5. Recurrent parotitis and immunodeficieny in childhood.

KÖKCÜ KARADAĞ Ş. İ., HANCIOĞLU G., KUTLUĞ Ş., AKAR Ö. S., YILDIRAN A.

19th biennial Meeting of the European Society for Immunodeficiencies, England, 14 October 2020, (Full Text)

6. Clinical Heterogeneity of Recombination activating Gene 2(RAG2) could be seen in G35A mutation

HANCIOĞLU G., ALTUNDAĞ E., ABUR Ü., YILDIRAN A.

2019 meeting of the European Society for Immunodeficiencies, 18 - 21 September 2019, (Full Text)

7. Hemophagocytic Syndrome with IKBKB and RAG2 homozygous mutations

HANCIOĞLU G., ALTUNDAĞ E., YILDIRAN A.

2019 Meeting of The European society for Immunodeficiencies, 18 - 21 September 2019, (Full Text)

8. A Noval Case With NFKB2 Mutation of Tatal Alopecia, Autoimmunity, Central Hypothyroism: Acombined Immunodeficiency

HANCIOĞLU G., ALTUNDAĞ E., YILDIRAN A.

2019 Meeting of the European Society For Immunodeficincies, 18 - 21 September 2019, (Full Text)

9. IKBKB GENİNDE HOMOZİGOT MUTASYONU OLAN AĞIR KOMBİNE İMMÜN YETMEZLİKLİ (SCID) BİR VAKA

ALTUNDAĞ E., AKAR Ö. S., HANCIOĞLU G., GÜMÜŞKAPTAN Ç., YILDIRAN A.

Uluslararası Katılımlı 13. Ulusal Tıbbi Genetik Kongresi, Antalya, Turkey, 7 - 11 November 2018, (Summary Text)

10. A TURKISH LRBA DEFICIENCY COHORT PROVIDING CLINICAL AND LABORATORYUTILITIES

KIYKIM A., DURSUN E., NAİN E., ÇEKİÇ Ş., ÖĞÜLÜR İ., BAŞER D., et al.

The 18th Biennial Meeting of ESID, Lizbon, Portugal, 24 - 27 October 2018, (Summary Text)

11. LRBA eksikliğinde CTLA-4 analoğunun (abatacept) lenfosit alt tipleri üzerine ex-vivo etkileri

KIYKIM A., ÖĞÜLÜR İ., Dursun E., YILDIRAN A., UNCUOĞLU A., KELEŞ S., et al.

İmmünolojide Moleküller Sempozyumu, İzmir, Turkey, 18 - 21 October 2018, (Summary Text)

12. Yenidoğanlarda Primer İmmün Yetmezlik Hastalıklarının PCR ile Taranması

KARADAĞ ALPASLAN M., KUTLUĞ Ş., borte s., ÖZYAZICI ÖZKAN S. E., YEŞİLIRMAK D. C., AYGÜN H. C., et al.

24.Ulusal Allerji ve Klinik İmmünoloji Kongresi 18-22 Kasım 2017 Antalya, Turkey, 18 - 22 November 2017, (Summary Text)

13. Diagnostics Of Primary Antibody Deficiencies Through Targeted Next Generation Sequencing Panel

NG Y. Y., FIRTINA S., HATIRNAZ N. Ö., camcıoğlu y., AYDINER E., KIYKIM A., et al.

International Primary Immunodeficiencies Congress, United Arab Emirates, 8 - 10 November 2017, (Summary Text)

14. MVK, NLRP3, TNFRSF1 and MEFV gene mutation profile of patients with autoinflammatory disease report of 286 pediatric patients from Northern Anatolia

ALTUNDAĞ E., OĞUR M. G., ABUR Ü., MUTLU ALBAYRAK H., Çeliksoy H., G.A.PAUL A., et al.

EUROPEAN HUMAN GENETICS CONFERENCE, 21 - 24 May 2016, (Summary Text)

15. MVK NLRP3 TNFRSF1A and MEFV gene mutation profile of patientswith autoinflammatory diseases report of 286 pediatric patients from Northern Anatolia

ALTUNDAĞ E., OĞUR M. G., ABUR Ü., MUTLU ALBAYRAK H., ÇELİKSOY H., G.A.PAUL A., et al.

EUROPEAN HUMAN GENETICS CONFERENCE, 21 - 24 May 2016, (Summary Text)

16. AKUT LÖSEMİ DE MLL GEN DÜZENSİZLİKLERİ VE 11 KROMOZOM İLİŞKİLİ TRANSLOKASYONLARIN PROGNOSTİK ETKİSİ

AYMELEK H. S., OĞUR M. G., ABUR Ü., AKAR Ö. S., ALTUNDAĞ E., YILDIRAN A., et al.

II.Hematolojik Genetik Sempozyumu 24-26 ŞUBAT İZMİR, İzmir, Turkey, 24 - 26 February 2016, (Summary Text)

17. Akut Lösemi de MLL Gen Düzensizlikleri ve 11. Kromozom İlişkili Translokasyonların Prognostik Etkisi

AYMELEK H. S., OĞUR M. G., ABUR Ü., AKAR Ö. S., ALTUNDAĞ E., YILDIRAN A., et al.

2. Hematolojik Genetik Sempozyumu, İzmir, Turkey, 24 - 26 February 2016, (Summary Text)

18. Clinical Features and HSCT Outcomes for SCID in Turkey

İKİNCİOĞULLARI K. A., ÇAĞDAŞ AYVAZ D. N., DOĞU E. F., Tugrul T., Karasu G., HASKOLOĞLU Z. Ş., et al.

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, (Summary Text)

19. Hematopoetic Stem Cell Transplantation (HSCT) for Primary Immunodeficiency Diseases (PIDS): Clinical Features and Outcome (A Single Center Experience)

AKELMA A. Z., DOĞU E. F., HASKOLOĞLU Z. Ş., Cipe F., Aytekin C., Reisli I., et al.

16th Biennial Meeting of the European-Society-for-Immunodeficiencies, Prague, Czech Republic, 29 October - 01 November 2014, (Summary Text)

20. COMPARISON OF PERIPHERAL BLOOD LYMPHOCYTE SUBPOPULATIONS AND RECENT THYMIC EMIGRANTS IN PATIENTS WITH ATAXIA TELANGIECTASIA AND AGE-MATCHED HEALTHY CHILDREN

Celiksoy M. H., TOPAL E., Yıldıran A.

100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, vol.34, pp.735, (Summary Text)

21. UNUSUAL CLINICAL PRESENTATION AND HEMOPHAGOCYTOSIS OF ATAXIA-TELANGIECTASIA IN TWO SIBLINGS WITH A RARE MUTATION

Yıldıran A., Celiksoy M. H., Guner S. N., Borte S.

100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, vol.34, pp.735, (Summary Text)

22. EARLY DIAGNOSIS OF LEUCOCYTE ADHESION MOLECULE DEFICIENCY TYPE 1

Guner S. N., Sayar E. H., EMİROĞLU M., Borte S., Yıldıran A., Reisli I.

100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, vol.34, pp.743, (Summary Text)

23. A SINGLE CENTER EXPERIENCE OF HSCT IN ANKARA

AKELMA A. Z., DOĞU E. F., HASKOLOĞLU Z. Ş., Cipe F., Aytekin C., Reisli I., et al.

100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, pp.732, (Summary Text)

24. IMMUNORECONSTITUTION IN THE FIRST THRE YEAR AFTER HSCT IN A NEWLY ESTABLISHED TRANSPLANTATION UNIT

Yıldıran A., Borte S., Elli M., Fisgin T.

100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, vol.34, pp.747, (Summary Text)

25. Pottential effects of stem cell derived from the peripheral nerve after crush injury in control and obese rats

KAYHAN KUŞTEPE E., ALTUNKAYNAK B. Z., YILDIRAN A., ALTUNKAYNAK M. E., TÜRKMEN A. P., ÖNGER M. E., et al.

2nd International Symposium on Peripheral Nerve Regeneration, Italy, 23 - 25 January 2014, (Summary Text)

26. SEVERE COMBINED IMMUNODEFICIENCY: CLINICAL, IMMUNOLOGICAL FEATURES AND OUTCOME IN 50 CASES

DOĞU E. F., Cipe F., Aytekin C., Karatas D., KENDİRLİ T., Yildiran A., et al.

15th Biennial Meeting European-Society-for-Immunodeficiency (ESID), Florence, Italy, 3 - 06 October 2012, pp.331-332, (Summary Text)

27. The prevalence of the food allergy in nursery and kindergarten students

Barlik F., Guner S., Kilic M., Barlik M., Ozturk F., Yildiran A., et al.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, pp.228, (Summary Text)

28. Complementary and alternative medicine in children with allergic diseases

Guner S., Kilic M., Ozturk F., Yildiran A., Sancak R.

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, pp.640-641, (Summary Text)

29. HİPONATREMİ-HİPERTANSİF SENDROMLA BAŞVURAN BİR RENAL ARTER STENOZU OLGUSU

NALÇACIOĞLU H., ÖZKAYA O., GENÇ G., BELET Ü., AKKUŞ L., YILDIRAN A.

6.ULUSAL ÇOCUK NEFROLOJİ KONGRESİ, Turkey, 7 - 10 October 2010, (Summary Text)

30. A child diagnosed as IL-12R deficient with disseminated BCG infection

Yildiran A., Ak E., Picard C., Sancak R.

29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 5 - 09 June 2010, pp.475, (Summary Text)

31. Combined Immunodeficiencies: Clinical, Immunological Features And Outcome Of 56 Cases From A Single Institution

İKİNCİOĞULLARI K. A., DOĞU E. F., Aytekin C., Cipe F. E., Yuksek M., Bozdogan G., et al.

66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, Louisiana, United States Of America, 26 February - 02 March 2010, (Summary Text)

32. Autoimmune thyroiditis after haplo-identical stem cell transplantation for severe combined immunodeficiency

DOĞU E. F., Cipe F., YILDIRAN AVCU Y., ŞIKLAR Z., Yuksek M., Ocal G., et al.

35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, Sweden, 29 March - 01 April 2009, (Summary Text)

33. Does the mode of delivery affect T regulatory (Treg) cells in cord blood?

YILDIRAN AVCU Y., Yurdakul E., Guloglu D., DOĞU E. F., Arsan S., Arikan M., et al.

28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Warszawa, Poland, 6 - 10 June 2009, pp.21, (Summary Text)

34. The outcome of haploidentical stem cell transplantation in severe combined immunodeficiencies -: a single-centre experience

Tanyildiz M., Pekpak E., DOĞU E. F., YILDIRAN AVCU Y., Cipe F., Yuksek M., et al.

34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, Italy, 30 March - 02 April 2008, (Summary Text)

35. HLA class I deficiency: Clinical, immunological and genetic characteristics of three patient

Ikinciogullari A., DOĞU E. F., Fricker D., Yuksek M., Bozdogan G., Aytekin C., et al.

64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, Pennsylvania, United States Of America, 14 - 18 March 2008, (Summary Text)

36. Plasma soluble endothelial protein C receptor (EPCR) levels in asthmatic children

UÇAR Y., DOĞU E. F., Guloglu D., Arykan M., YILDIRAN AVCU Y., Cipe F., et al.

27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, Barcelona, Spain, 7 - 11 June 2008, pp.313, (Summary Text)

37. Could serum MMP-9 level and MMP-9/TIMP-1 ratio be used as a serological marker for airway remodelling?

DOĞU E. F., YILDIRAN AVCU Y., Guloglu D., Erol F., Yuksek M., Babacan E., et al.

26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, Goteborg, Sweden, 9 - 13 June 2007, pp.195-196, (Summary Text)

38. A successful T-lymphocyte engraftment achieved by megadose CD34+selected peripheral blood stem cell transplantation in a T-B-NK plus SCID case without using conditioning regimen

Ikinciogullari A., Aytekin C., DOĞU E. F., Yuksek M., YILDIRAN AVCU Y., Bozdogan G., et al.

32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group, Hamburg, Germany, 19 - 22 March 2006, (Summary Text)